Log in or Sign up for Free to view tailored content for your specialty!
Surgery News
Untreated aortic stenosis confers poor survival regardless if moderate or severe
PARIS — Patients with aortic stenosis have poor survival rates if their condition is left untreated, regardless of whether their stenosis is moderate or severe, researchers reported at the European Society of Cardiology Congress.
SYNTAXES: No mortality difference at 10 years with PCI or CABG
PARIS — Ten-year follow-up data from the SYNTAXES trial highlight no significant difference in all-cause death among patients who underwent PCI using first-generation paclitaxel-eluting stents or CABG.
Log in or Sign up for Free to view tailored content for your specialty!
Rivaroxaban monotherapy noninferior to combo therapy for AF, stable CAD
PARIS — In the AFIRE trial, rivaroxaban monotherapy was noninferior to rivaroxaban plus an antiplatelet agent with respect to CV events and death from any cause, and was superior for major bleeding in patients with atrial fibrillation and stable CAD.
POPular AGE: Clopidogrel remains an option for elderly with ACS
PARIS — New data from the POPular AGE study support the use of clopidogrel over ticagrelor and prasugrel, based on significant reduction in bleeding, in patients aged 70 years and older with non-ST-elevation ACS.
Early anticoagulation may reduce stroke risk after surgical AVR
Early anticoagulation after bioprosthetic aortic valve replacement was associated with short-term reduced risk for stroke in patients who had surgical AVR but not in those who had transcatheter AVR, researchers reported.
ODYSSEY OUTCOMES: Alirocumab reduces CV event risk for polyvascular disease, CABG
Alirocumab reduced the risk for major adverse CV events and death in patients with recent ACS and polyvascular disease and in those with CABG after an ACS event, according to two analyses of the ODYSSEY OUTCOMES trial published in the Journal of the American College of Cardiology.
Viable myocardium not linked to long-term CABG benefit for ischemic cardiomyopathy
Myocardial viability was not linked to a long-term benefit from CABG in patients with ischemic cardiomyopathy, according to results from the STICH study published in The New England Journal of Medicine.
Cardiac rehab referral rates lacking after CICU discharge, especially for patients with HF
In a new study, nearly 63% of patients discharged from the cardiac ICU had an indication for cardiac rehabilitation, yet only 30% were referred upon discharge.
Statin use promotes limb salvage, survival after PAD procedures
Among patients with peripheral artery disease who underwent a surgical or endovascular intervention, statin use after the procedure was associated with better odds of survival and limb salvage, researchers reported.
New catheter-based procedure adds option for PDA closure in newborns
Newborns with the congenital heart defect patent ductus arteriosus face many potential complications such as respiratory failure, acute kidney injury, necrotizing enterocolitis and HF. But closing it has been much easier said than done.